Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Chairman’s Address to Shareholders 2020 Annual General Meeting

November 18, 2020November 18, 2020 Alterity Therapeutics

Chairman’s Address to Shareholders 2020 AGM

Post navigation

Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases

AGM 2020 Presentation

Related Posts

Prana’s Alzheimer’s Disease Treatment Strategy Validated by Independent Study

March 6, 2014

Alterity completes Placement Tranche 1 raising $10M

October 23, 2020October 27, 2020

The Lancet Neurology publishes Prana’s Huntington’s Disease Trial

November 18, 2014

Leave a Reply Cancel reply

Your email address will not be published.Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.

Recent Posts

AGM 2020 Presentation
Chairman’s Address to Shareholders 2020 Annual General Meeting
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study
Alterity completes Placement Tranche 1 raising $10M

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065